BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2534035)

  • 1. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
    Damon LE; Christensen S; Rochlitz C; Cadman EC
    Anticancer Res; 1989; 9(6):1761-7. PubMed ID: 2534035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition.
    Yin MB; Rustum YM
    Cancer Commun; 1991 Feb; 3(2):45-51. PubMed ID: 1825284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
    Dorr RT; Liddil JD; Gerner EW
    Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E; Moroson BA; Bertino JR
    Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
    Moran RG; Scanlon KL
    Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments.
    Jensen PB; Sørensen BS; Sehested M; Grue P; Demant EJ; Hansen HH
    Cancer Res; 1994 Jun; 54(11):2959-63. PubMed ID: 8187081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
    Kerrigan D; Pommier Y; Kohn KW
    NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A.
    Vichi PJ; Tritton TR
    Cancer Res; 1993 Nov; 53(21):5237-43. PubMed ID: 8106144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
    Mancini WR; Stetson PL; Lawrence TS; Wagner JG; Greenberg HS; Ensminger WD
    Cancer Res; 1991 Feb; 51(3):870-4. PubMed ID: 1824826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
    Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate.
    Canman CE; Lawrence TS; Shewach DS; Tang HY; Maybaum J
    Cancer Res; 1993 Nov; 53(21):5219-24. PubMed ID: 8221659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-dependent synergism between dichloromethotrexate and 5-fluorouracil in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Res; 1983 Sep; 43(9):4011-13. PubMed ID: 6871843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in culture.
    Cory JG; Halley MC; Jeney A; Lapis K
    Cancer Res; 1990 Aug; 50(15):4552-6. PubMed ID: 2142444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical rationale for the synergism of 5-fluorouracil and folinic acid.
    Moran RG; Keyomarsi K
    NCI Monogr; 1987; (5):159-63. PubMed ID: 2963229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.